Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides

Journal of Dermatological Science

Volumn 65, Issue 2, 2012, Pages 102-109

  Dworschak, Jenny ^a   Recke, Andreas ^a   Freitag, Miriam ^a   Ludwig, Ralf J ^a   Langenhan, Jana ^b   Kreuzer, Oliver J ^c   Zillikens, Detlef ^a   Schmidt, Enno ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Institute of Experimental Immunology   (Germany)

^c Peptides and Elephants GmbH   (Germany)

Author keywords

Autoimmunity; Desmoglein 3; Linear epitopes; Pemphigus vulgaris

Indexed keywords

AUTOANTIBODY; DESMOGLEIN 3 ANTIBODY; EPITOPE; IMMUNOGLOBULIN G; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMAN; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PEMPHIGUS VULGARIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN;

ANIMALS; ANIMALS, NEWBORN; AUTOANTIBODIES; CASE-CONTROL STUDIES; CELL LINE; DESMOGLEIN 3; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; GERMANY; HUMANS; IMMUNIZATION, PASSIVE; INJECTIONS, SUBCUTANEOUS; KERATINOCYTES; MICE; MICE, INBRED BALB C; PEMPHIGUS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY;

EID: 84856487520     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2011.11.012     Document Type: Article

References (35)

1. Amagai M., Klaus-Kovtun V., Stanley J.R. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell 1991, 67(5):869-877.
2. Ding X., Aoki V., Mascaro J.M., Lopez-Swiderski A., Diaz L.A., Fairley J.A. Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol 1997, 109(4):592-596.
3. Amagai M., Tsunoda K., Zillikens D., Nagai T., Nishikawa T. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999, 40(2 Pt 1):167-170.
4. Jamora M.J., Jiao D., Bystryn J.C. Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 2003, 48(6):976-977.
5. Miyagawa S., Amagai M., Iida T., Yamamoto Y., Nishikawa T., Shirai T. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression. Br J Dermatol 1999, 141(6):1084-1087.
6. Schiltz J.R., Michel B. Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum. J Invest Dermatol 1976, 67(2):254-260.
7. Anhalt G.J., Labib R.S., Voorhees J.J., Beals T.F., Diaz L.A. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med 1982, 306(20):1189-1196.
8. Rock B., Labib R.S., Diaz L.A. Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest 1990, 85(1):296-299.
9. Amagai M., Hashimoto T., Shimizu N., Nishikawa T. Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus. J Clin Invest 1994, 94(1):59-67.
10. Sharma P., Mao X., Payne a S. Beyond steric hindrance: the role of adhesion signaling pathways in the pathogenesis of pemphigus. J Dermatol Sci 2007, 48(1):1-14.
11. Waschke J. The desmosome and pemphigus. Histochem Cell Biol 2008, 130(1):21-54.
12. Getsios S., Waschke J., Borradori L., Hertl M., Muller E.J. From cell signaling to novel therapeutic concepts: international pemphigus meeting on advances in pemphigus research and therapy. J Invest Dermatol 2010, 130(7):1764-1768.
13. Schiltz J.R., Michel B., Papay R. Pemphigus antibody interaction with human epidermal cells in culture. J Clin Invest 1978, 62(4):778-788.
14. Dusek R.L., Godsel L.M., Green K.J. Discriminating roles of desmosomal cadherins: beyond desmosomal adhesion. J Dermatol Sci 2007, 45(1):7-21.
15. Amagai M., Karpati S., Prussick R., Klaus-Kovtun V., Stanley J.R. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992, 90(3):919-926.
16. Futei Y., Amagai M., Sekiguchi M., Nishifuji K., Fujii Y., Nishikawa T. Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris. J Invest Dermatol 2000, 115(5):829-834.
17. Sekiguchi M., Futei Y., Fujii Y., Iwasaki T., Nishikawa T., Amagai M. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 2001, 167(9):5439-5448.
18. Müller R., Svoboda V., Wenzel E., Muller H.H., Hertl M. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris. Exp Dermatol 2008, 17(1):35-43.
19. Müller R., Svoboda V., Wenzel E., Gebert S., Hunzelmann N., Muller H.H., et al. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris. Exp Dermatol 2006, 15(8):606-614.
20. Cirillo N., Femiano F., Gombos F., Lanza A. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes. Immunol Lett 2009, 122(2):208-213.
21. Kawasaki H., Tsunoda K., Hata T., Ishii K., Yamada T., Amagai M. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation. J Invest Dermatol 2006, 126(12):2621-2630.
22. Tsunoda K., Ota T., Aoki M., Yamada T., Nagai T., Nakagawa T., et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003, 170(4):2170-2178.
23. Anzai H., Fujii Y., Nishifuji K., Aoki-Ota M., Ota T., Amagai M., et al. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris. J Dermatol Sci 2004, 35(2):133-142.
24. Schmidt E., Dahnrich C., Rosemann A., Probst C., Komorowski L., Saschenbrecker S., et al. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol 2010, 19(5):458-463.
25. Sitaru C., Powell J., Messer G., Brocker E.B., Wojnarowska F., Zillikens D. Immunoblotting and enzyme-linked immunosorbent assay for the diagnosis of pemphigoid gestationis. Obstet Gynecol 2004, 103(4):757-763.
26. Heupel W.M., Engerer P., Schmidt E., Waschke J. Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor. Am J Pathol 2009, 174(2):475-485.
27. Ishii K., Harada R., Matsuo I., Shirakata Y., Hashimoto K., Amagai M. In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris. J Invest Dermatol 2005, 124(5):939-946.
28. Schmidt E., Gutberlet J., Siegmund D., Berg D., Wajant H., Waschke J. Apoptosis is not required for acantholysis in pemphigus vulgaris. Am J Physiol Cell Physiol 2009, 296(1):C162-C172.
29. ++ concentration. J Invest Dermatol 1987, 89(2):167-171.
30. Amagai M., Ishii K., Hashimoto T., Gamou S., Shimizu N., Nishikawa T. Conformational epitopes of pemphigus antigens (Dsg1 and Dsg3) are calcium dependent and glycosylation independent. J Invest Dermatol 1995, 105(2):243-247.
31. Heupel W.M., Muller T., Efthymiadis A., Schmidt E., Drenckhahn D., Waschke J. Peptides targeting the Desmoglein 3 adhesive interface prevent autoantibody-induced acantholysis in pemphigus. J Biol Chem 2009, 284(13):8589-8595.
32. Yokouchi M., Saleh M.A., Kuroda K., Hachiya T., Stanley J.R., Amagai M., et al. Pathogenic epitopes of autoantibodies in pemphigus reside in the amino-terminal adhesive region of desmogleins which are unmasked by proteolytic processing of prosequence. J Invest Dermatol 2009.
33. Hacker M.K., Janson M., Fairley J.A., Lin M.S. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Clin Immunol 2002, 105(1):64-74.
34. Payne a S., Ishii K., Kacir S., Lin C., Li H., Hanakawa Y., et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 2005, 115(4):888-899.
35. Lanza A., Perillo L., Landi C., Femiano F., Gombos F., Cirillo N. Controversial role of antibodies against linear epitopes of desmoglein 3 in pemphigus vulgaris, as revealed by semiquantitative living cell immunofluorescence microscopy and in-cell ELISA. Int J Immunopathol Pharmacol 2010, 23(4):1047-1055.